Cellectar Biosciences, Inc.·4

Jun 14, 4:31 PM ET

NEIS JOHN 4

4 · Cellectar Biosciences, Inc. · Filed Jun 14, 2019

Insider Transaction Report

Form 4
Period: 2019-06-13
NEIS JOHN
Director
Transactions
  • Award

    Stock option (right to buy)

    2019-06-13+6,5006,500 total
    Exercise: $2.15Exp: 2029-06-13Common Stock (6,500 underlying)
Footnotes (1)
  • [F1]Options vest on the one year anniversary of the date of grant.

Documents

1 file
  • 4
    tv523611_4.xmlPrimary

    OWNERSHIP DOCUMENT